References
- Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero‐Luna G, Martinez‐Tyson D, Jemal A, Siegel RL. Cancer statistics for hispanics/latinos, 2018. CA Cancer J Clin. 2018;68:425–45.
- Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–82. doi:https://doi.org/10.1016/S0140-6736(18)32470-X
- Almeida AM, Queiroz JA, Sousa F, Sousa Â. Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins. Drug Discov Today. 2019;24:2044–57. doi:https://doi.org/10.1016/j.drudis.2019.07.011
- de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70. doi:https://doi.org/10.1002/ijc.30716
- Zhang Y, Jia L, Wang P, Li J, Tian F, Chu ZP, Kang S. The expression and significance of lncRNA HOST2 and microRNA let-7b in HPV-positive cervical cancer tissues and cell lines. Eur Rev Med Pharmacol Sci. 2019;23:2380. doi:https://doi.org/10.26355/eurrev_201903_17384
- Kuzuhara T, Suganuma M, Fujiki H. Green tea catechin as a chemical chaperone in cancer prevention. Cancer Lett. 2008;261:12–20. doi:https://doi.org/10.1016/j.canlet.2007.10.037
- Hara-Terawaki A, Takagaki A, Kobayashi H, Nanjo F. Inhibitory activity of catechin metabolites produced by intestinal microbiota on proliferation of HeLa cells. Biol Pharm Bull. 2017;40:1331–5. doi:https://doi.org/10.1248/bpb.b17-00127
- Cai Z-Y, Li X-M, Liang J-P, Xiang L-P, Wang K-R, Shi Y-L, Yang R, Shi M, Ye J-H, Lu J-L, et al. Bioavailability of Tea Catechins and Its Improvement. Molecules 2018;23(9):2346. doi:https://doi.org/10.3390/molecules23092346
- Takagaki A, Nanjo F. Catabolism of (+)-catechin and (−)-epicatechin by rat intestinal microbiota. J Agric Food Chem. 2013;61:4927–35. doi:https://doi.org/10.1021/jf304431v
- Sun H, Chen Y, Cheng M, Zhang X, Zheng X, Zhang Z. The modulatory effect of polyphenols from green tea, oolong tea and black tea on human intestinal microbiota in vitro. J Food Sci Technol. 2018;55:399–407. doi:https://doi.org/10.1007/s13197-017-2951-7
- Giordano A, Tommonaro G. Curcumin and cancer. Nutrients. 2019;11:2376. doi:https://doi.org/10.3390/nu11102376
- Kasi PD, Tamilselvam R, Skalicka-Woźniak K, Nabavi SF, Daglia M, Bishayee A, Pazoki-Toroudi H, Nabavi SM. Molecular targets of curcumin for cancer therapy: an updated review. Tumor Biol. 2016;37:13017–28. doi:https://doi.org/10.1007/s13277-016-5183-y
- Zhou S, Zhang S, Shen H, Chen W, Xu H, Chen X, Sun D, Zhong S, Zhao J, Tang J. Curcumin inhibits cancer progression through regulating expression of microRNAs. Tumor Biol. 2017;39:1010428317691680. doi:https://doi.org/10.1177/1010428317691680
- Alizadeh N, Asadi M, Shanehbandi D, Zafari V, Shomali N, Asvadi T, Sepehri B. Evaluation of the methylation of MIR129-2 gene in gastric cancer. J Gastrointest Cancer. 2020;51:267–70. doi:https://doi.org/10.1007/s12029-019-00239-4
- Shomali N, Shirafkan N, Duijf PHG, Ghasabi M, Babaloo Z, Yousefi M, Mansoori B, Asadi M, Shanehbandi D, Baghbani E, et al. Downregulation of miR-146a promotes cell migration in Helicobacter pylori-negative gastric cancer. J Cell Biochem. 2019;120:9495–505. doi:https://doi.org/10.1002/jcb.28225
- Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer–a brief overview. Adv Bio Regul. 2015;57:1–9. doi:https://doi.org/10.1016/j.jbior.2014.09.013
- Tamjidifar R, Akbari M, Tarzi S, Sadeghzadeh M, Abolghasemi M, Poursaei E, Shomali N, Mahdavi F. Prognostic and diagnostic values of miR-506 and SPON 1 in colorectal cancer with clinicopathological considerations. J Gastrointest Cancer. 2021;52(1):125–9. doi:https://doi.org/10.1007/s12029-019-00356-0
- Nabipoorashrafi SA, Shomali N, Sadat-Hatamnezhad L, Mahami-Oskouei M, Mahmoudi J, Sandoghchian Shotorbani B, Akbari M, Xu H, Sandoghchian Shotorbani S. miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro. IUBMB Life. 2020;72:2034–44. doi:https://doi.org/10.1002/iub.2345
- Qin Q, Furong W, Baosheng L. Multiple functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer Res. 2014;33:50. doi:https://doi.org/10.1186/1756-9966-33-50
- Aghdam SG, Ebrazeh M, Hemmatzadeh M, Seyfizadeh N, Shabgah AG, Azizi G, Ebrahimi N, Babaie F, Mohammadi H. The role of microRNAs in prostate cancer migration, invasion, and metastasis. J Cell Physiol. 2019;234:9927–42. doi:https://doi.org/10.1002/jcp.27948
- Pfeffer SR, Yang CH, Pfeffer LM. The role of miR‐21 in cancer. Drug Dev Res. 2015;76:270–7. doi:https://doi.org/10.1002/ddr.21257
- Ebrahimi F, Gopalan V, Smith RA, Lam AK-Y. miR-126 in human cancers: clinical roles and current perspectives. Exp Mol Pathol. 2014;96:98–107. doi:https://doi.org/10.1016/j.yexmp.2013.12.004
- Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, Masamune A, Kikuta K, Kume K, Shimosegawa T. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res. 2012;10:3–10. doi:https://doi.org/10.1158/1541-7786.MCR-11-0272
- Sabry D, El-Deek SEM, Maher M, El-Baz MAH, El-Bader HM, Amer E, Hassan EA, Fathy W, El-Deek HEM. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Mol Cell Biochem. 2019;454(1-2):177–89. doi:https://doi.org/10.1007/s11010-018-3462-1
- Guo Y, Liao Y, Jia C, Ren J, Wang J, Li T. MicroRNA-182 promotes tumor cell growth by targeting transcription elongation factor A-like 7 in endometrial carcinoma. Cell Physiol Biochem. 2013;32:581–90.: doi:https://doi.org/10.1159/000354462
- Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, Muschel RJ, Beech J, Kulshrestha R, Abdelmohsen K, Weinstock DM, et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell. 2011;41:210–20. doi:https://doi.org/10.1016/j.molcel.2010.12.005
- Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176:1248–64. doi:https://doi.org/10.1016/j.cell.2019.01.021
- Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69(3):4–10. doi:https://doi.org/10.1159/000088478
- Danbaran GR, Aslani S, Sharafkandi N, Hemmatzadeh M, Hosseinzadeh R, Azizi G, Jadidi-Niaragh F, Babaie F, Mohammadi H. How microRNAs affect the PD-L1 and its synthetic pathway in cancer. Int Immunopharmacol. 2020;84:106594. doi:https://doi.org/10.1016/j.intimp.2020.106594
- Brant AC, Menezes AN, Felix SP, de Almeida LM, Sammeth M, Moreira MA. Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: a descriptive study in invasive cervical cancer. Genomics. 2019;111:1853–61. doi:https://doi.org/10.1016/j.ygeno.2018.12.008
- Hsu EM, McNicol PJ. Characterization of HPV-16 E6/E7 transcription in CaSki cells by quantitative PCR. Mol Cell Probes. 1992;6:459–66. doi:https://doi.org/10.1016/0890-8508(92)90042-v
- Przystupski D, Michel O, Rossowska J, Kwiatkowski S, Saczko J, Kulbacka J. The modulatory effect of green tea catechin on drug resistance in human ovarian cancer cells. Med Chem Res. 2019;28(5):657–67. doi:https://doi.org/10.1007/s00044-019-02324-6
- Flowers LC, Stephens KW, Huang RP, Mohammed S. Curcumin suppresses growth of cervical cancer cells. AACR. 2005;65:1011–2.
- Kim JH, Park SH, Nam SW, Kwon HJ, Kim BW, Kim WJ, Choi YH. Curcumin stimulates proliferation, stemness acting signals and migration of 3T3-L1 preadipocytes. Int J Mol Med. 2011;28:429–35. doi:https://doi.org/10.3892/ijmm.2011.680
- Sun H, Tang F, Zhou S, Li X, Wang S, Huang K, Jia Y, Tian X, Ma D, Li S, et al. Association between vascular endothelial growth factor expression and lymph node metastasis in cervical cancer: a meta-analysis. J Obstet Gynaecol Res. 2016;42(10):1310–6. doi:https://doi.org/10.1111/jog.13064
- Kim YH, Kim MA, Park IA, Park WY, Kim JW, Kim SC, Park NH, Song YS, Kang SB. VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival. Gynecol Oncol. 2010;119:232–6. doi:https://doi.org/10.1016/j.ygyno.2010.07.035
- Tang FY, Nguyen N, Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer. 2003;106:871–8. doi:https://doi.org/10.1002/ijc.11325
- Negrão R, Costa R, Duarte D, Gomes TT, Azevedo I, Soares R. Different effects of catechin on angiogenesis and inflammation depending on VEGF levels. J Nutr Biochem. 2013;24:435–44. doi:https://doi.org/10.1016/j.jnutbio.2011.12.011
- Perez-Moral N, Needs PW, Moyle CWA, Kroon PA. Hydrophobic interactions drive binding between vascular endothelial growth factor-A (VEGFA) and polyphenolic inhibitors. Molecules 2019;24:2785. doi:https://doi.org/10.3390/molecules24152785
- Zhou H, Chen JX, Yang CS, Yang MQ, Deng Y, Wang H. Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer. BMC Genomics. 2014;15 Suppl 11:S3. doi:https://doi.org/10.1186/1471-2164-15-s11-s3
- Fix LN, Shah M, Efferth T, Farwell MA, Zhang B. MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60. Cancer Genom Proteom. 2010;7:261–77.
- Jiang L, Tao C, He A, He X. Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate. World J Surg Oncol. 2014;12:383. doi:https://doi.org/10.1186/1477-7819-12-383
- Chu KO, Chan KP, Chan SO, Ng TK, Jhanji V, Wang CC, Pang CP. Metabolomics of green-tea catechins on vascular-endothelial-growth-factor-stimulated human-endothelial-cell survival. J Agric Food Chem. 2018;66:12866–75. doi:https://doi.org/10.1021/acs.jafc.8b05998
- Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer. 2006;118:1635–44. doi:https://doi.org/10.1002/ijc.21545
- Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, Abrial C, Mouret-Reynier MA, Durando X, Barthomeuf C, Chollet P. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther. 2010;9:8–14. doi:https://doi.org/10.4161/cbt.9.1.10392
- Kumar P, Barua CC, Sulakhiya K, Sharma RK. Curcumin ameliorates cisplatin-induced nephrotoxicity and potentiates its anticancer activity in SD rats: potential role of curcumin in breast cancer chemotherapy. Front Pharmacol. 2017;8:132. doi:https://doi.org/10.3389/fphar.2017.00132
- Rajitha B, Belalcazar A, Nagaraju GP, Shaib WL, Snyder JP, Shoji M, Pattnaik S, Alam A, El-Rayes BF. Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer. Cancer Lett. 2016;373:227–33. doi:https://doi.org/10.1016/j.canlet.2016.01.052
- Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC, Chung JG. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF). Cancer Lett. 2009;285:127–33. doi:https://doi.org/10.1016/j.canlet.2009.04.037
- Binion DG, Otterson MF, Rafiee P. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut. 2008;57:1509–1517. doi:https://doi.org/10.1136/gut.2008.152496
- Gattoc L, Frew PM, Thomas SN, Easley KA, Ward L, Chow HS, Ura CA, Flowers L. Phase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia. Open Access J Clin Trials. 2017;9:1–10. doi:https://doi.org/10.2147/OAJCT.S105010
- Shang HS, Chang CH, Chou YR, Yeh MY, Au MK, Lu HF, Chu YL, Chou HM, Chou HC, Shih YL, et al. Curcumin causes DNA damage and affects associated protein expression in HeLa human cervical cancer cells. Oncol Rep. 2016;36:2207–15. doi:https://doi.org/10.3892/or.2016.5002
- Mudduluru G, George-William JN, Muppala S, Asangani IA, Kumarswamy R, Nelson LD, Allgayer H. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep. 2011;31(3):185–97. doi:https://doi.org/10.1042/BSR20100065
- Gao W, Chan JY, Wong TS. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p. Clin Sci (Lond). 2014;127:571–9. doi:https://doi.org/10.1042/cs20140010
- Howell JC, Chun E, Farrell AN, Hur EY, Caroti CM, Iuvone PM, Haque R. Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells. Mol Vision. 2013;19:544.
- Li Y, Tian L, Sun D, Yin D. Curcumin ameliorates atherosclerosis through upregulation of miR‐126. J Cell Physiol. 2019;234:21049–21059. doi:https://doi.org/10.1002/jcp.28708